6 of the best performing ASX All Ords stocks in the past year
6 of the best performing ASX All Ords stocks in the past year Clarity Pharmaceuticals (ASX:CU6) Clarity is a…
Does Macquarie Group (ASX:MQG) deserve its reputation as the ‘millionaires factory’? And will it continue into FY25?
Macquarie Group (ASX:MQG) has a reputation as the ‘millionaire’s factory’, and it did not just develop it by accident. Despite…
Does your company have an underperforming board? Here’s how to get rid of them: A s.249D notice!
Has your company got an underperforming board running your company and want to replace them? It’s possible and easy in…
Should I buy AGL Energy (ASX:AGL) as a hedge against inflation in FY25?
Should I buy AGL Energy (ASX:AGL)? That’s a question many investors would be forgiven for asking themselves when hearing that…
As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts
Here 6 ASX stocks that will benefit from lower interest rates! AGL Energy (ASX:AGL) You might think AGL is…
CSL (ASX:CSL): Expecting double-digit earnings growth for the rest of the 2020s
CSL is the ASX’s largest healthcare stock and the third biggest company behind BHP (ASX:BHP) and CBA (ASX:CBA). Capped at…
Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?
Not many ASX medtech companies can boast of a then US President elect as a patient, but Curvebeam AI (ASX:CVB)…
Here are 5 of the worst stock market crashes of all time
If you thought the recent correction was bad, you thought wrong – it pales in comparison to the worst stock…
Mirvac (ASX:MGR): Things are set to get worse before they get better
Founded in 1972, Mirvac (ASX:MGR) is Australia’s largest listed developer of residential, commercial and industrial property. Arguably, it is one…
Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?
If you thought you were having a bad Monday, spare a thought for Actinogen Medical (ASX:ACW) shareholders who saw their…
Eli Lilly (NYSE:LLY): Is this US$700bn company the biggest threat to Novo Nordisk & Ozempic?
For investors who missed out on Novo Nordisk, or reckon it is overvalued, Eli Lilly (NYSE:LLY) could be the next…
Here are 4 family owned ASX companies to watch eagerly
Family owned ASX companies are a rare breed. We’re not talking about companies that are still founder-led, we’re talking about…
If my company gets hit by a ASX Price Query, what does it mean and is it good or bad?
An ASX price query, or a speeding ticket, is commonly issued to ASX companies that record unexpected share price movements…
What is the VIX and what are the factors that cause it to violently surge and go into tailspins?
You may hear the occasional passing comment that the market is volatile, but the VIX Index (also known as the…
Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1
Is a new era on the horizon for ASX BNPL stocks? After a boom that lasted from Afterpay’s May 2016…